Clinical trial
Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
NCT00181818 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00181818 |
|---|---|
| Title | Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease |
| Official title | Safety and Efficacy of Sustained-Release (SR) Bupropion for Smokers Hospitalized Smokers With Acute Coronary Heart Disease |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Smoking, Myocardial Infarction, Unstable Angina, Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | bupropion SR (sustained-release) |
| Enrollment | 248 |
| Start date | Oct 1, 1999 |
| Completion | Dec 1, 2003 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: